Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.
Study sponsor: Alaunos Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2014-08-07Actual
Enrollment · participants12Actual
Source updated2025-08-28Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.